Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts, 2013

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2013-12-05: Form 8-K; Exhibit 10.1; Description FOURTH AMENDMENT TO LEASE, DATED AS OF NOV 30, 2013 ARE-SF AND PBI.
  • 2013-08-13: Form 10-Q; Exhibit 10.3; Description Master Process Development and Clinical Supply Agreement, dated as of June 23, 2010, as amended August 1, 2011, by and among Elan Pharma International Limited, Neotope Biosciences limited and Boehringer Ingelheim Pharma GmbH & Co. KG.
  • 2013-08-13: Form 10-Q; Exhibit 10.2; Description Amendment No. 1 to Tax Matters Agreement, dated June 25, 2013, by and between Elan Corporation, plc and Prothena Corporation plc.
  • 2013-05-22: Form 8-K; Exhibit 10.1; Description Offer Letter dated April 19, 2013, by and between Prothena Biosciences Inc and Karin L. Walker.
FiledFormExhibitDescription
2013-12-058-K10.1FOURTH AMENDMENT TO LEASE, DATED AS OF NOV 30, 2013 ARE-SF AND PBI
2013-08-1310-Q10.3Master Process Development and Clinical Supply Agreement, dated as of June 23, 2010, as amended August 1, 2011, by and among Elan Pharma International Limited, Neotope Biosciences limited and Boehringer Ingelheim Pharma GmbH & Co. KG
2013-08-1310-Q10.2Amendment No. 1 to Tax Matters Agreement, dated June 25, 2013, by and between Elan Corporation, plc and Prothena Corporation plc
2013-05-228-K10.1Offer Letter dated April 19, 2013, by and between Prothena Biosciences Inc and Karin L. Walker
2013-03-2910-K10.20Offer letter, dated December 14, 2012, between Prothena Biosciences Inc and Tara Nickerson
2013-03-2910-K10.18Offer letter, dated December 22, 2012, between Prothena Biosciences Inc. and Gene Kinney
2013-03-2910-K10.12Prothena Biosciences Inc. Amended and Restated Severance Plan
2013-03-288-K10.2Offer Letter dated March 19, 2013, by and between Prothena Biosciences Inc and Martin Koller.
2013-03-288-K10.1Offer Letter dated March 20, 2013, by and between Prothena Biosciences Inc and Tran Nguyen.
2013-01-258-K10.1EMPLOYMENT AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10